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An Orphan Nuclear Receptor Activated by Pregnanes
Defines a Novel Steroid Signaling Pathway
1993). Once inside the nucleus, the activated receptors
regulate the expression of target genes by binding as
homodimers to short DNA sequence motifs, termed hor-
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S-171 77 Stockholm receptors differ from their steroid hormone receptor
Sweden counterparts in several respects (Mangelsdorf and Evans,
‖The Ludwig Institute for Cancer Research 1995; Mangelsdorf et al., 1995). First, the nonsteroid
Stockholm Branch hormone receptors are not sequestered in the cyto-
S-171 77 Stockholm plasm in the absence of their cognate ligands but in-
Sweden stead reside within the nucleus. Second, whereas ste-
roid hormone receptors generally bind to their HREs as
homodimers, most of the nonsteroid hormone receptors
Summary identified to date bind to DNA as heterodimers with
the 9-cis retinoic acid receptors (RXRs) (Glass, 1994;
Steroid hormones exert profound effects on differenti- Mangelsdorf and Evans, 1995). Finally, the two classes
ation, development, and homeostasis in higher eu- of receptors recognize different types of HREs: steroid
karyotes through interactions with nuclear receptors. hormone receptors generally bind to HREs composed
We describe a novel orphan nuclear receptor, termed of two half-sites organized as a palindrome with a three-
the pregnane X receptor (PXR), that is activated by nucleotide spacer, while nonsteroid hormone receptors
naturally occurring steroids such as pregnenolone and preferentially bind to HREs composed of two half-sites
progesterone, and synthetic glucocorticoids and anti-
organized as a direct repeat (DR), with the number and
glucocorticoids. PXR exists as two isoforms, PXR.1
composition of the nucleotides separating the half-sitesand PXR.2, that are differentially activated by steroids.
serving as important determinants of receptor selectivityNotably, PXR.1 is efficaciously activated by pregneno-
(Umesono et al., 1991; Glass, 1994; Mangelsdorf andlone 16a-carbonitrile, a glucocorticoid receptor an-
Evans, 1995).tagonist that induces the expression of the CYP3A
In addition to receptors with established ligands, ap-family of steroid hydroxylases and modulates sterol
proximately 30 other members of the nuclear hormoneand bile acid biosynthesis in vivo. Our results provide
receptor family have been isolated from vertebrates.evidence for the existence of a novel steroid hormone
These related proteins lack identified ligands and, as asignaling pathway with potential implications in the
consequence, have been termed orphan nuclear recep-regulation of steroid hormone and sterol homeostasis.
tors (Evans, 1988; Mangelsdorf and Evans, 1995; En-
mark and Gustafsson, 1996). The search for hormonalIntroduction
activators of the orphan receptors has created exciting
opportunities to discover novel endocrine signalingSteroid hormones are cholesterol derivatives that serve
pathways with implications in both normal physiologyas signaling molecules to coordinate the expression of
and disease. Work with orphan nuclear receptors hascomplex gene programs in higher eukaryotes. These
led to the identification of fatty acids and eicosanoidsmolecules exert their effects by diffusing into cells and
as ligands for the peroxisome proliferator±activated re-interacting with specific intracellular receptors. Recep-
tors for each of the major classes of sex and adrenal ceptors (Forman et al., 1997; Kliewer et al., 1997; Krey
steroids have been characterized (Evans, 1988; Beato et al., 1997), retinoids and farnesoids as activators of
et al., 1995; Mangelsdorf et al., 1995). In the absence of RIP14/FXR (Forman et al., 1995; Zavacki et al., 1997),
their cognate ligands, the steroid hormone receptors and various oxysterols as activators of the LXR and SF-1
remain sequestered in the cytoplasm through interac- orphan nuclear receptors (Janowski et al., 1996; Lala et
tions with large multiprotein complexes containing heat al., 1997; Lehmann et al., 1997).
shock proteins. However, the binding of ligand causes In this report, we describe a novel orphan nuclear
the steroid hormone receptors to be released from these receptor, which we have designated PXR for pregnane
complexes and translocated into the nucleus (Pratt, X receptor. Like nonsteroid hormone receptors, PXR
binds as a heterodimer with RXR toan HRE composed of
two half-sites organized as a DR. Surprisingly, however,# To whom correspondence should be addressed.
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PXR is efficaciously activated by several steroids, in-
cluding naturallyoccurring pregnanesand synthetic glu-
cocorticoids and antiglucocorticoids. Thus, PXR com-
bines features of both thesteroid and nonsteroidnuclear
receptors. We suggest that PXR defines a novel steroid
hormone signaling pathway that may account for at least
some of the effects of synthetic glucocorticoids and
antiglucocorticoids that do not appear to be mediated
through the classical glucocorticoid receptor (GR) sig-
naling pathway.
Results
Cloning of PXR.1 and PXR.2
In an effort to identify new members of the nuclear re-
ceptor family, we performed a series of motif searches
of public EST databases. These searches revealed a
clone from a mouse liver library in the Washington Uni-
versity/HHMI EST database that had homology to the
ligand-binding domains (LBDs) of a number of nuclear
receptors. We used this partial sequence information to
isolate larger clones from a mouse liver cDNA library.
The nucleotide sequence of the longest cDNA clone
encodes a novel orphan nuclear receptor of 431 amino
acids that we have designated PXR.1 (Figure 1A). We
also isolated a second cDNA clone, termed PXR.2, that
was identical to PXR.1 except for the deletion of a
stretch of 123 nucleotides extending from base pairs
661 to 783 (Figure 1A). Examination of the PXR genomic
structure revealed that PXR.2 represents a splice variant
of PXR.1 lacking a single exon (data not shown). The
PXR.2 cDNA encodes a 390 amino acid protein that
lacks a 41 amino acid region in the putative LBD of
PXR.1. Sequence alignment with nuclear receptors for
which the crystal structures have been solved indicates
that the 41 amino acids that distinguish the PXR iso-
forms lie between helices two and three of the canonical
LBD structure (Wurtz et al., 1996).
Sequence comparison with other members of the nu-
clear receptor family showed that the PXR isoforms are
most closely related to the Xenopus laevis orphan nu-
clear receptor 1 (ONR1) (Smith et al., 1994), with PXR.2
and ONR1 sharing 70% and 46% amino acid identity in Figure 1. PXR is a Member of the Nuclear Receptor Superfamily
their DNA-binding domains (DBDs) and LBDs, respec-
(A) Nucleotide and predicted amino acid sequence of mouse PXR.
tively (Figure 1B). Based upon this degree of homology, The upstream in-frame stop codon is in bold. The predicted start
it is unclear at present whether PXR represents the initiation codon is at nucleotide 151. The 123 nucleotide region
extending from base pairs 661 to 783 that is present in PXR.1 andmammalian homolog of ONR1. With regard to mamma-
absent in PXR.2 is underlined. A putative polyadenylation signal inlian receptors, PXR is most closely related to the vitamin
the 39 untranslated region is boxed.D receptor (VDR) (Baker et al., 1988), sharing 64% and
(B) Amino acid sequence comparison between murine PXR and
39% identity in the DBD and LBD, respectively. other members of the nuclear hormone receptor family. Similarity
between PXR and other nuclear hormone receptor family members
in the DNA- and ligand-binding domains are indicated as percentPXR Expression Pattern in the Embryo
amino acid identity. The 41 amino acid region that distinguishesand the Adult PXR.1 from PXR.2 is indicated by the cross-hatched area. All com-
The expression pattern of PXR was examined in both parisons were madewith the PXR.2 isoform. ONR1, Xenopus orphan
adult and embryonic tissues. Northern blot analysis was nuclear receptor 1; VDR, human vitamin D receptor; TRb, human
thyroid hormone receptor b; RARa, human retinoic acid receptor a;performed under high-stringency conditions with blots
GR, human glucocorticoid receptor.that included poly(A)1 RNA prepared from multiple adult
mouse tissues and a probe that recognized both PXR
isoforms. Abundant expression of PXR mRNA was ob- and 4.4 kb that were expressed at lower levels (Figure
2A). Weaker expression of the PXR mRNA was alsoserved only in the liver and intestine, where three distinct
messages were detected including a highly expressed detected in kidney and stomach (Figure 2A). No PXR
mRNA was detected in the other tissues examined.mRNA species of 2.6 kb and two transcripts of 1.9 kb
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PXR Is Activated by Synthetic Pregnanes
and Glucocorticoids
We next sought to determine whether PXR, like other
members of the nuclear receptor family, possesses tran-
scriptional activity that can be regulated in a hormone-
dependent manner. As we lacked knowledge of a cog-
nate HRE for PXR, we initially performed searches for
activators using an established chimera system in which
the LBDs of the two PXR isoforms were fused to the
DBD of the yeast transcription factor GAL4 (Lehmann
et al., 1995). Expression vectors for the GAL4-PXR chi-
meras were transiently transfected into CV-1 cells to-
gether with a reporter plasmid containing five copies of a
GAL4 DNAbinding site upstream of the chloramphenicol
acetyltransferase (CAT) reporter. Transfected CV-1 cells
were systematically treated with a series of natural and
synthetic compounds that included steroids, vitamin D
analogs, thyroid hormone analogs, retinoids, fatty acids,
and other small, lipophilic molecules, and reporter levels
measured.
Interestingly, we found that the activity of the GAL4-
PXR.1 chimera was markedly induced by 10 mM con-
centrations of a variety of synthetic steroids including
the glucocorticoids dexamethasone, dexamethasone-t-
butyl-acetate, and dexamethasone-21-acetate, and the
pregnenolone derivative 6,16a-dimethyl pregnenolone
(Figure 3B). Dexamethasone-t-butylacetate and 6,16a-
dimethyl pregnenolone were the most efficacious of these
compounds (Figure 3B).Remarkably, we found that PXR.1
was not only activated by GR agonists, but also by theFigure 2. ExpressionPattern of PXR inAdult and Embryonic Tissues
GR antagonists RU486 and pregnenolone 16a-carboni-(A) Northern blot analysis. RNA size markers (in kb) are indicated
at left. Arrows at right indicate the three species of PXR transcripts trile (PCN) (Figure 3B). RU486 is a potent antiprogestin
that were detected. (B-D) In situ hybridization analysis of PXRmRNA that binds to theGR at nanomolar concentrations (Cade-
expression in E18 mouse embryo sections with a probe that recog- pond et al., 1997). PCN is a weaker antagonist that has
nized both PXR isoforms (see probe 1 in Experimental Procedures).
been shown to interfere with GR-mediated activation(B) Phosphoimage of an entire sagittal section showing specific
at micromolar concentrations (Schuetz and Guzelian,labeling in intestine and liver. Specificity was ascertained by compe-
1984; Schuetz et al., 1984). Thus, the LBD of PXR.1 wastition with a 100-fold excess of unlabeled, specific oligonucleotide.
This resulted in complete inhibition of labeling in liver and intestine efficaciously activated by bothagonists and antagonists
while nonspecific signals remained in developing bone. (C and D) of the GR.
High power bright-field microscopy showing the abundance of silver Notably, the GAL4-PXR.2 chimera displayed a much
grains in the liver (C) and in the intestine (D) where mRNA labeling
more restricted activation profile. Of the steroids thatwas confined to the epithelium. The bar in (B) corresponds to 2 mM,
activated GAL4-PXR.1, only dexamethasone-t-butyl-and in (C) and (D) to 50 mM.
acetate activated GAL4-PXR.2 efficiently (Figure 3B).
We conclude that the 41 amino acid deletion that distin-The embryonic expression pattern of PXR was exam-
guishes PXR.2 from PXR.1 has a marked effect on theined via in situ hybridization analysis using sections pre-
responsiveness of the orphan receptor to synthetic ste-pared from day 18 (E18) mouse embryos. Three oligonu-
roids.cleotide probes were designed that recognized PXR,
including two that interacted with both PXR isoform
PXR Functions through a Response ElementmRNAs and a third that hybridized only to PXR.1 mRNA.
Conserved in the CYP3A Gene PromotersPXR mRNA was detected in the liver and intestine (Fig-
PCN and dexamethasone treatment have previouslyures 2B±2D). Staining in the intestine was confined to
been shown to induce the expression of the CYP3Athe epithelium (Figure 2D). No PXR expression was de-
family of genes in rodent liver, intestine, and kidneytected in embryonic kidney, adrenal, lung, thymus, heart,
as well as in primary cultures of rodent hepatocytesskeletal muscle, brain, or spinal cord (data not shown).
(Elshourbagy and Guzelian, 1980; Heuman et al., 1982;While similar results were obtained with all three PXR
Hardwick et al., 1983; Schuetz and Guzelian, 1984;probes, the signal intensity in liver and intestine was
Schuetz et al., 1984; Gonzalez et al., 1985; Debri etconsistently higher in experiments performed with the
al., 1995). The CYP3A genes encode cytochrome P450probes that recognize both PXR isoforms (data not
hemoproteins involved in the hydroxylation of steroidshown), suggesting that PXR.2 is expressed in tissues
hormones, including corticosteroids, progestins, andro-that also express PXR.1. We conclude from the Northern
gens, and DHEA-sulfate, as well as a variety of xenobiot-blot and in situ hybridization analyses that PXR is abun-
ics (Nebert and Gonzalez, 1987; Juchau, 1990). The re-dantly expressed in only a few tissues, including the
liver and intestine, in both the mouse embryo and adult. sponse to PCN and dexamethasone occurs at the level
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Figure 3. Synthetic Glucocorticoids and Pregnenolone Derivatives
Activate PXR
(A) Structures of the steroids that activate the GAL4-PXR chimeric
Figure 4. PXR Binds as a Heterodimer with RXRa to DR-3 Responseproteins.
Elements Present in the CYP3A1 and CYP3A2 Gene Promoters(B) CV-1 cells were cotransfected with expression plasmids encod-
(A) Alignment of DR-3 motifs present in the promoter regions of theing either GAL4-PXR.1 (filled bars) or GAL4-PXR.2 (open bars) and
CYP3A1 and CYP3A2 genes. A mutated derivative of the CYP3A1the reporter plasmid (UAS)5-tk-CAT. Cells were treated with vehicle
DR-3 motif (DCYP3A1) used in the gel mobility shift assays and thealone (0.1% DMSO) or 10 mM of the indicated steroids. Cell extracts
position of the mutations is also shown.were subsequently assayed for CAT activity. Data represent the
(B) Gel mobility shift assays were performed with a radiolabeledmean of five data points from two different experiments 6 SD.
oligonucleotide containing the CYP3A1 DR-3 and in vitro synthe-
sized PXR.1, PXR.2, and RXRa as indicated.
of transcription and has been mapped to a conserved (C) Gel mobility shift assays were performed with PXR.1 and RXRa
(top panel) or PXR.2 and RXRa (bottom panel) and radiolabeledregion within the CYP3A1 and CYP3A2 gene promoters
oligonucleotide containing the CYP3A1 DR-3 in the presence ofthat does not contain a typical glucocorticoid response
either a 5-fold or 25-fold excess of unlabeled oligonucleotides con-element, but instead contains a DR of the nonsteroid
taining the CYP3A1 DR-3, a mutated CYP3A1 DR-3 (DCYP3A1), ornuclear receptor half-site sequence AGTTCA separated
the CYP3A2 DR-3 as indicated.
by a three-nucleotide spacer, a so-called DR-3 motif
(Figure 4A) (Umesono et al., 1991; Miyata et al., 1995;
Quattrochi et al., 1995; Huss et al., 1996). These data efficiently to the CYP3A1 DR-3 as heterodimers with
RXRa (Figure 4B). The PXR-RXRa complex with DNAhave led to speculation that a nonsteroid nuclear hor-
mone receptor might be involved in mediating the ef- was competed efficiently by an excess of unlabeled
CYP3A1 DR-3 oligonucleotide or an oligonucleotidefects of PCN and dexamethasone.
Given that PXR shares a high degree of homology containing a closely related DR-3 motif from the CYP3A2
gene promoter (Figures 4A and 4C). No competition waswith ONR1 and VDR in the DBD (Figure 1B) and that
both ONR1 and VDR preferentially bind to DR-3 HREs seen with an oligonucleotide containing a mutated
CYP3A1 DR-3 motif (Figures 4A and 4C). Thus, bothas heterodimers with RXR (Umesono et al., 1991; Smith
et al., 1994; Mangelsdorf and Evans, 1995), we postu- PXR isoforms can bind specifically as heterodimers with
RXRa to DR-3 motifs found in the promoter regions oflated that PXR might bind to the CYP3A1 and CYP3A2
DR-3 motifs as a heterodimer with RXR. In order to test CYP3A genes.
We next asked whether the PXR isoforms could in-this idea, gel mobility shift assays were performed using
a radiolabeled oligonucleotide containing the CYP3A1 duce gene expression through the CYP3A1 DR-3 ele-
ment in response to steroids. Transient transfectionDR-3 motif and in vitro synthesized PXR.1, PXR.2, and
RXRa. Neither PXR nor RXRa bound to the CYP3A1 assays were performed with a reporter plasmid con-
taining two copies of the CYP3A1 DR-3 motif insertedDR-3 alone. However, both PXR.1 and PXR.2 bound
Pregnane X Receptor, a Novel Steroid Receptor
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activated by dexamethasone-t-butylacetate (Figure 5A).
Dose±response analysis revealed dexamethasone-t-
butylacetate to be a significantly more potent activator
of PXR.1 than PXR.2, with EC50 values of 0.8 and 5 mM
for PXR.1 and PXR.2, respectively (Figures 5B and 5C).
Consistent with the results obtained using the GAL4-
PXR chimeras, 6,16a-dimethyl pregnenolone, PCN, and
RU486 activated full-length PXR.1 on the CYP3A1 re-
sponse element but failed to activate full-length PXR.2
(Figures 5B and 5C). 6,16a-dimethyl pregnenolone was
the most potent of these compounds, activating PXR.1
with an EC50 value of 300 nM (Figure 5B). Based upon
these data, we conclude that the full-length PXR iso-
forms can activate gene expression through the CYP3A1
DR-3 motif in response to synthetic steroids.
PXRs Are Activated by Naturally
Occurring Steroids
As PXR was activated by synthetic steroids, we exam-
ined whether a naturally occurring steroid might serve
as the endogenous hormone for PXR. Accordingly, CV-1
cells were transfected with expression plasmids for
either of the full-length PXR isoforms and the (CYP3A1)2-
tk-CAT reporter and treated with a variety of natural
steroids, including progestins, glucocorticoids, min-
eralocorticoids, androgens, estrogens, bile acids, and
oxysterols. Both PXR.1 and PXR.2 were activated by
micromolar concentrations of certain of these steroids.
Consistent with our findings that the pregnenolone de-
rivatives 6,16a-dimethyl pregnenolone and PCN activate
PXR.1, pregnenolone and its metabolites 17a-hydroxy-
pregnenolone, progesterone, 17a-hydroxyprogesterone,
and 5b-pregnane-3,20-dione activated PXR.1 (Figure
6B). Dose±response analysis revealed that all five of
these pregnanes activated PXR.1 with EC50 values in the
5±20 mM range (Figure 6C). Since PXR.1 is activated by
synthetic glucocorticoids, we were surprised to find that
naturally occurring glucocorticoids, including cortisol
and corticosterone, had virtually no effect on PXR.1 ac-
tivity (data not shown).
In analogous cotransfection experiments performed
Figure 5. Synthetic Glucocorticoids and Pregnenolone Derivatives with PXR.2, only 5b-pregnane-3,20-dione was found to
Activate PXR through the CYP3A1 DR-3 induce reporter activity .5-fold (Figure 6B). Notably,
(A) CV-1 cells were cotransfected with expression plasmids for full- pregnenolone, progesterone, and their 17a-hydroxyl-
length PXR.1 or PXR.2 and the (CYP3A1)2-tk-CAT reporter plasmid. ated derivatives, which were efficacious activators of
Cells were treated with either vehicle (0.1% DMSO) alone (open PXR.1, had little or no activity on PXR.2 (Figure 6B).
bars) or 10 mM dexamethasone-t-butylacetate (filled bars). Cell ex-
Thus, while both PXR isoforms are activated by naturallytracts were subsequently assayed for CAT activity.
occurring pregnanes, PXR.1 is activated by a broader(B and C) CV-1 cells were cotransfected with expression plasmids
range of these steroids than PXR.2. The generation offor full-length PXR.1 (B) or PXR.2 (C) and the (CYP3A1)2-tk-CAT
reporter plasmid. Transfected cells were treated with the indicated LBD isoforms with distinct activation profiles provides
concentrations of 6,16a-dimethyl pregnenolone (closed circles), dexa- a novel mechanism for increasing the regulatory diver-
methasone-t-butylacetate (open circles), PCN (closed squares), or sity in the PXR signaling pathway.
RU486 (open squares). Cell extracts were subsequently assayed for
CAT activity and data plotted as the percentage of the maximal
response obtained. Data points represent the mean of assays per-
Steroids Promote the Interaction of PXRformed in triplicate. Similar resultswere obtained in two independent
experiments. with a Coactivator Protein
We next sought to address whether the steroids that
activated PXR did so through direct interactions withupstream of the minimal thymidine kinase promoter and
the LBD. Due to the lack of radiolabeled derivativesthe CAT gene [(CYP3A1)2-tk-CAT]. Interestingly, in the
of the more potent PXR activators, we were unable toabsence of steroids, PXR.1 was found to have a roughly
perform standard binding analyses. However, a number20-fold higher basal level of activity than PXR.2 (Figure
5A). Nevertheless, both PXR isoforms were efficiently of laboratories have recently demonstrated that ligands
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and nonsteroid nuclear hormone receptors in a ligand-
dependent fashion (Onate et al., 1995; Horwitz et al.,
1996; Kamei et al., 1996; Takeshita et al., 1996). The
interaction of SRC-1 with nuclear receptors is depen-
dent upon the amino acid motif LXXLL found in multiple
copies in SRC-1 (Heery et al., 1997; Torchia et al., 1997).
In an effort to determine whether the steroid activators
of PXR serve as ligands for this orphan receptor, we
tested whether a 14 kDa fragment of SRC-1 (SRC-1.14)
containing three LXXLL motifs interacted with PXR in a
steroid-dependent manner.
SRC-1.14 was expressed in vitro and labeled with
[35S]-methionine and [35S]-cysteine, and the LBD of
PXR.1 was expressed in E. coli as a fusion protein with
glutathione-S-transferase (GST). Coprecipitation exper-
iments were performed in the presence of the most
potent PXR activators including 6,16a-dimethyl preg-
nenolone, dexamethasone-t-butylacetate, and PCN.
[35S]-SRC-1.14 interacted only weakly with the GST-
PXR.1LBD fusion protein in the absence of added com-
pound (Figure 7A). The interaction of [35S]-SRC-1.14 with
GST-PXR.1LBD was significantly enhanced in the pres-
ence of either dexamethasone-t-butylacetate, 6,16a-
dimethyl pregnenolone, or PCN (Figure 7A). Additional
experiments performed with 6,16a-dimethyl pregneno-
lone and PCN revealed that these steroids promoted
[35S]-SRC-1.14/PXR.1LBD interactions in a dose-depen-
dent manner (Figure 7B). Consistent with the results of
the transfection studies, 6,16a-dimethyl pregnenolone
was more potent than PCN in promoting these interac-
tions (Figure 7B). Estradiol did not stimulate interactions
between PXR.1 and [35S]-SRC-1.14, indicating that the
enhancement was specific for compounds that activate
PXR.1 in the transfection assay (Figure 7A). In control
experiments, estradiolpromoted theefficient interaction
of [35S]-SRC-1.14 with a GST-ERaLBD fusion protein
(Figure 7A). However, GST-ERaLBD interactions with
[35S]-SRC-1.14 were not induced in thepresence of PCN,
Figure 6. Naturally Occurring Steroids Activate PXR dexamethasone-t-butylacetate, or 6,16a-dimethyl preg-
(A) Structures of naturally occurring steroids that activate PXR. nenolone. Taken together, these data provide strong
(B) CV-1 cells were cotransfected with expression plasmids for full-
evidence that PCN, dexamethasone-t-butylacetate, andlength PXR.1 (filled bars) or PXR.2 (open bars) and the (CYP3A1)2-
6,16a-dimethyl pregnenolone serve as ligands for PXR.tk-CAT reporter plasmid. Transfected cells were treated with 10 mM
of the indicated steroids. Cell extracts were subsequently assayed
for CAT activity and data plotted as fold-activation relative to cells Discussion
treated with vehicle (0.1% DMSO) alone. Data points represent the
mean of assays performed in triplicate 6 SD. Identification of a Novel Signaling Pathway
(C) Transfected cells were treated with the indicated concentrations for Steroidsof pregnenolone (closed circles), 17a-hydroxypregnenolone (open
It was first observed over 50 years ago that repeatedcircles), progesterone (triangles), 17a-hydroxyprogesterone (open
administration of high doses of certain steroids, includ-squares), or 5b-pregnane-3,20-dione (closed squares). Cell extracts
were subsequently assayed for CAT activity and data plotted as ing progestins and androgens, reduced their own and
fold-activation relative to cells treated with vehicle (0.1% DMSO) each others toxic effects. These early observations, to-
alone. Data points represent the mean of assays performed in tripli- gether with the later findings that resistance to numer-
cate. Similar results were obtained in two independent experiments.
ous drugs is sex dependent, that castration of rodents
leads to increased drug sensitivity, and that liver homog-
enates of intact male rats metabolize certain drugs more
for nuclear receptors induce their interaction with pro- rapidly than homogenates prepared from castrated ani-
teins required for optimal transcriptional activation, the mals led to the concept of ªcatatoxicº steroids; that
so-called coactivator proteins (Horwitz et al., 1996). is, steroids that confer resistance to specific toxins by
These ligand-dependent interactions have been ex- accelerating their metabolism (reviewed by Kourounakis
ploited as a biochemical assay for demonstrating direct et al., 1977). It was speculated that catatoxic agents
interactions between ligands and their cognate recep- might have utility in the treatment of patients suffering
tors (Krey et al., 1997). from either drug intoxication or from diseases caused
The steroid receptor coactivator protein-1 (SRC-1) by endogenous substances liable to metabolism (e.g.,
Cushing's syndrome) (Kourounakis et al., 1977).has been shown to interact directly with both steroid
Pregnane X Receptor, a Novel Steroid Receptor
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Quattrochi et al.,1995). This response element was com-
posed of two copies of the nuclear receptor half-site
consensus sequence AGTTCA organized as a DR.
In addition to PCN, the expression of CYP3A1 was
also shown to be induced by dexamethasone both in
vivo and in cultured hepatocytes (Heuman et al., 1982;
Schuetz and Guzelian, 1984; Schuetz et al., 1984). How-
ever, the concentrations of dexamethasone required to
induce CYP3A gene expression were higher than those
typically required to activate the classical GR signaling
pathway (Schuetz and Guzelian, 1984; Schuetz et al.,
1984). Promoter mapping studies showed that dexa-
methasone induced CYP3A1 gene expression through
the same DR response element as PCN (Quattrochi et
al., 1995; Huss et al., 1996). Thus, paradoxically, both
high concentrations of dexamethasone, a glucocorti-
coid, and PCN, an antiglucocorticoid, induced the ex-
pression of the CYP3A1 gene through the same re-
sponse element.
We now provide several lines of evidence indicating
that the orphan nuclear receptor PXR is responsible for
mediating the inductive effects of PCN and dexametha-
sone on CYP3A gene expression. First, both dexametha-
sone and PCN are efficacious activators of the PXR.1
isoform. Second, PXR binds efficiently as a heterodimerFigure 7. Steroids Induce PXR Interactions with a Fragment of the
with RXR to the conserved DR-3 motifs identified in theCoactivator Protein SRC-1
CYP3A1 and CYP3A2 gene promoters as glucocorticoid(A) Coprecipitation experiments were performed with bacterially ex-
and PCN response elements. Finally, we detected PXRpressed GST-PXR.1LBD (upper panel) or GST-ERaLBD(lower panel)
expression in only a few tissues, including liver, intes-and [35S]-SRC-1.14 synthesized in vitro. [35S]-SRC-1.14 was mixed
with either GST-PXR.1LBD or GST-ERaLBD in the presence of vehi- tine, and kidney. These are the primary tissues in which
cle alone (1% DMSO) or 10 mM of estradiol, PCN, dexamethasone- the CYP3A genes are expressed and induced in re-
t-butylacetate, or 6,16a-dimethyl pregnenolone as indicated. [35S]- sponse to either dexamethasone or PCN treatment
SRC-1.14 complexed with either GST-PXR.1LBD or GST-ERaLBD (Heuman et al., 1982; Debri et al., 1995). Our data thus
was precipitated with glutathione-sepharose beads as described in
support the existence of a novel signaling pathway forExperimental Procedures. A lane representing 10% of the input [35S]-
synthetic glucocorticoids and provide a mechanistic ex-SRC-1.14 in each reaction is shown on the left. Western blot analysis
planation for the long-standing paradox as to how bothwith an anti-GST antibody revealed that comparable amounts of
GST-PXR.1LBD and GST-ERaLBD fusion proteins were used in the GR agonists and antagonists can exert similar effects
assays (data not shown). on CYP3A gene expression. Moreover, the identification
(B) Dose±response analysis was performed with [35S]-SRC-1.14 and of PXR.1 as the PCN receptor provides the tool neces-
GST-PXR.1LBD in the presence of the indicated concentrations of sary for the rapid identification of novel pharmacological
6,16a-dimethyl pregnenolone (squares) or PCN (circles). [35S]-SRC-
agents with more potent catatoxic activities.1.14 was quantitated via scanning densitometry and plotted as a
In addition to inducing CYP3A gene expression, PCNpercent of the [35S]-SRC-1.14 precipitated in the presence of 10 mM
is also known to have marked effects on hepatic choles-6,16a-dimethyl pregnenolone. Data shown represent the average
of duplicate points, andsimilar results wereobtained in two separate terol homeostasis in rodents. These effects include sig-
experiments. nificant decreases in the levels of HMG-CoA reductase
and cholesterol 7a-hydroxylase gene expression with
A systematic analysis of steroids in the early 1970s concomitant reductions in sterol biosynthesis and bile
identified the pregnenolone derivative PCN as the most acid secretion (von Bergmann et al., 1975; Mason and
Boyd, 1978; Turley and Dietschy, 1984; Stahlberg, 1995).potent catatoxic compound among those tested (Selye,
1971). Insight into the mechanism underlying the cata- PCN has also been reported to enhance the formation of
cholesterol-esters and the hypersecretion of cholesteroltoxic effects of PCN was provided by the demonstration
that this synthetic steroid induces the expression of into the bile (von Bergmann et al., 1975; Turley and
Dietschy, 1984). Thus, PCN affects key aspects of cho-CYP3A1 and CYP3A2, two closely related members of
the P450 family of monooxygenases (Elshourbagy and lesterol metabolism including its biosynthesis, storage,
and secretion. Although we cannot exclude the possibil-Guzelian, 1980; Heuman et al., 1982; Hardwick et al.,
1983; Schuetz and Guzelian, 1984; Schuetz et al., 1984; ity that some of its biological effects might be mediated
through the GR or other steroid receptors, it is temptingGonzalez et al., 1985). The CYP3A hemoproteins have
a remarkably broad substrate specificity, hydroxylating to speculate that PCN is mimicking the actions of an
endogenous hormone that serves to regulate coordi-a variety of xenobiotics such as cyclosporin, warfarin,
and erythromycin, as well as endogenous steroids in- nately steroid and sterol metabolism through the activa-
tion of PXR in tissues such as liver and intestine. Ourcluding cortisol, progesterone, testosterone, and DHEA-
sulfate (Nebert and Gonzalez, 1987; Juchau, 1990). Sub- data raise the possibility of the existence of regulatory
loops through which endogenous PXR hormones feedsequent studies with the cloned CYP3A1 gene promoter
identified a PCN response element that was highly con- back to regulate cholesterol homeostasis and feed for-
ward to regulate steroid homeostasis.served in the CYP3A2 gene promoter (Miyata et al.,1995;
Cell
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PA), respectively. All other steroids were purchased from eitherWhat is the natural ligand for PXR? Pregnenolone
Sigma Chemical Co. (St. Louis, MO) or Steraloids, Inc. (Wilton, NH).and progesterone are among the most potent naturally
occurring PXR activators that we have identified, acti-
Molecular Cloning of PXR cDNAs
vating PXR.1 at low micromolar concentrations. Preg- Partial mouse sequence for PXR was obtained from an EST depos-
nenolone is one of the most abundant steroids in ited in the Washington University/HHMI EST database (accession
mammals, circulating in humans and rodents at concen- number AA277370). A 19 bp oligonucleotide derived from this EST
sequence (59 TCTCCCCAGATCGTCCTGG 39) was used to screen atrations that range from roughly 1 to 50 nM (Punjabi
pCMV-SPORT mouse liver cDNA library (GIBCO-BRL) using Geneet al., 1983; Wichmann et al., 1984; Tietz, 1995). While
Trapper solution hybridization cloning technology (GIBCO-BRL).progesterone levels in human serum are generally in
Five clones were obtained that ranged in size from 1.0 kb to 2.7 kb.
the 1±10 nM range, concentrations can exceed 700 nM Four of these clones encoded PXR.1 and one encoded the DBD
during the third trimester of pregnancy (Tietz, 1995). and LBD of PXR.2. A clone encoding the full-length PXR.2 isoform±
These levels approach those required to activate PXR.1 coding region (nucleotides 151 to 1443) was subsequently isolated
from mouse liver cDNA through PCR. Sequences were aligned andin vitro. Nevertheless, it remains unclear whether con-
analyzed by the University of Wisconsin Genetics Computer Groupcentrations of progesterone or pregnenolone sufficient
programs.to activate PXR.1 are achieved either in serum or in
tissues under normal physiological conditions. Our re- Plasmids
sults with PXR may thus be analogous to those obtained The expression plasmids pSG5-GAL4-PXR.1LBD and pSG5-GAL4-
with RXR, which was first shown to be activated by PXR.2LBD were generated by amplification of cDNA encoding
amino acids 105±431 of PXR.1 or 105±390 of PXR.2 by PCR andmicromolar concentrations of all-trans retinoic acid
insertion into a modified pSG5 expression vector (Stratagene) con-(t-RA) prior to the identification of 9-cis RA as a high-
taining DNA encoding the DBD of GAL4 (amino acids 1±147) andaffinity ligand (Mangelsdorf et al., 1990; Heyman et al.,
the SV40 Tag nuclear localization signal (APKKKRKVG) inserted1992; Levin et al., 1992). Based upon our findings that
upstream of a multiple cloning site. The (UAS)5-tk-CAT reporter plas-PXR is activated by pregnenolone and its metabolites mid has been previously described (Lehmann et al., 1995). The ex-
and that the synthetic steroid 6,16a-dimethyl pregneno- pression vectors pSG5-PXR.1 and pSG5-PXR.2 were generated by
lone activates PXR with an EC50 value of 300 nM, we amplification of cDNA encoding amino acids 1±431 of PXR.1 or
1±390 of PXR.2 and insertion into pSG5. The reporter plasmidsuggest that the natural PXR ligand is likely to be a
(CYP3A1)2-tk-CAT was generated by insertion of two copies of apregnane.
double-stranded oligonucleotide containing the CYP3A1 DR-3 RE
(59 GATCAGACAGTTCATGAAGTTCATCTAGATC 39) (Quattrochi etPerspectives al., 1995; Huss et al., 1996) into the BamHI site of pBLCAT2 (Luckow
With the isolation of the androgen receptor in 1988 and SchuÈ tz, 1987). The bacterial expression vector pGEX-PXR.1LBD
(Chang et al., 1988; Lubahn et al., 1988), receptors for was generated by PCR amplification of cDNA encoding amino acids
105±431 of PXR.1 and insertion into a pGEX-2T vector (Pharmacia)all of the known nuclear-acting steroid hormones had
that had been modified to contain KpnI and NotI restriction sites.been cloned. However, studies performed during the
The bacterial expression vector pGEX-ERaLBD was generated bypast two years with orphan members of the nuclear
PCR amplification of cDNA encoding amino acids 251±595 of humanreceptor family have suggested that additional sterols
ERa (Green et al., 1986) and insertion into pGEX-2T. The expression
are likely to serve as mammalian hormones. For exam- plasmid for the SRC-1.14 fragment was generated by PCR amplifica-
ple, the orphan receptors LXR and SF-1 were recently tion of DNA encoding amino acids 632±754 of human SRC-1 (Take-
shown to be activated by physiological concentrations shita et al., 1996) and insertion into the expression vector pRSETC
(Invitrogen). All constructs were confirmed by sequence analysis.of several oxysterol metabolites of cholesterol (Janow-
ski et al., 1996; Lala et al., 1997; Lehmann et al., 1997).
Cotransfection AssaysWhile the biological role of LXR remains less clear, SF-1
CV-1 cells were plated in 24-well plates in DME medium supple-
is essential for adrenal and gonadal development and mented with 10% charcoal-stripped fetal calf serum at a density of
regulates the expression of genes required for steroido- 1.2 3 105 cells per well. In general, transfection mixes contained 33
genesis (Luo et al., 1994). These data suggested an ng of receptor expression vector, 100 ng of reporter plasmid, 200
unexpected hormonal function for oxysterols in the reg- ng of b-galactosidase expression vector (pCH110, Pharmacia), and
166 ng of carrier plasmid. Cells were transfected overnight by lipo-ulation of steroidogenesis.
fection using Lipofectamine (Life Technologies, Inc.) according toWe have now identified PXR as a novel member of
the manufacturer's instructions. The medium was changed to DMEthe nuclear receptor family that is efficaciously activated
medium supplemented with 10% delipidated calf serum (Sigma) and
by both natural and synthetic steroids. The activation cells were incubated for an additional 24 hr. Cell extracts were
profile of PXR is distinct from any of the other steroid prepared and assayed for CAT and b-galactosidase activities as
hormone receptors identified to date, suggesting that described previously (Lehmann et al., 1995).
this orphan receptor defines a novel endocrine signaling
Northern Analysispathway. We conclude that the identification of PXR
An approximately 1.0 kb fragment encoding the LBD of PXR.1 (nu-provides additional evidence for an expanded role for
cleotides 463±1446) was 32P-labeled by random priming using thesteroid hormones in mammalian physiology and that the
T7 Quick-Prime kit (Pharmacia). This radiolabeled fragment was
elucidation of the biological role of PXR is likely to lead used to probe mouse multiple-tissue Northern blots (OriGene, Rock-
to a better understanding of how steroids elicit their ville, MD). Blots were hybridized in ExpressHyb solution (Clontech,
myriad effects. Palo Alto, CA) at 658C for 18 hr. Final washes were performed with
0.13 SSC, 0.1% SDS at 658C.
Experimental Procedures
In Situ Hybridization Analysis
Embryonic day 18 (E18) mice (C57bl/CBA and NMRI, BomholtChemicals
Breeding and Research Center, Copenhagen, Denmark) were usedDexamethasone-t-butylacetate and RU486 were purchased from
Research Plus, Inc. (Bayonne, NJ) and Biomol (Plymouth Meeting, in the studies. Tissues were sectioned at 14 mm and thaw-mounted
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onto slides (ProbeOn, Fischer). Three different oligonucleotide the transient transfection studies and data analysis; Nick Tomkinson
probes (Pharmacia Biotech, Sollentuna, Sweden) designed to hy- for assistance in compound selection; Dave Morris and Lars Olson
bridize to PXR mRNA were used. Oligonucleotides were radiola- for support and encouragement throughout these studies; and John
beled using [35S]-deoxyadenosine 59-a-thio-triphosphate (NEN) at Didsbury for comments on the manuscript. This work was supported
the 39 end using terminal deoxynucleotidyl transferase (Amersham). by grants from the Swedish Research Council to T. P. and R. H. Z.
Labeled oligonucleotides were hybridized to tissue sections and
mRNA expression was first detected by phosphoimaging (BASF
Received October 30, 1997; revised November 20, 1997.3000 Phosphoimager, Fuji) followed by film emulsion autoradiogra-
phy (Dagerlind et al., 1992). Sections were examined using light-
and dark-field microscopy (Axiophot, Zeiss) and photographed
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